Penumbra, Inc.

The latest read

Computed from the data on Oct 23, 2026. Every figure links back to its source in the sections below.

• Revenue over the four quarters to June 30, 2026: $1.50 billion, up 17% from a year earlier.SEC EDGAR filings (XBRL)
• Free cash flow (operating cash flow minus capital expenditure) over the four quarters to June 30, 2026: $0.22 billion, up 38% from a year earlier.SEC EDGAR filings (XBRL)
• Capital expenditure over the four quarters to June 30, 2026: $0.06 billion, up 50% from a year earlier.SEC EDGAR filings (XBRL)
• Latest earnings call or results release (July 30, 2026): sentiment 0.00 on a −1 to +1 scale (mixed), confidence 0.00 of 1.Palanor Discourse
• Latest annual report (filed February 25, 2026): 6 risk factors added, 0 removed.Risk Factor Changes (10-K Item 1A)
• Insiders were net sellers in Q2 2026: $0.0 million on the open market.SEC Form 4
• 452 institutional managers reported a position at June 30, 2026 (−33 on the quarter before).SEC Form 13F
• H-1B filings certified in Q2 2026: 26 (17 a year earlier).U.S. Department of Labor (OFLC)

Latest WARN notice: Aug 20, 2024 →

Company Posture covers S&P 500 companies.

No bond term sheets or tagged debt on file for Penumbra, Inc. yet.

0 actions in the last 12 months · 0 workers in WARN notices · latest Aug 20, 2024

1. Aug 20, 2024WARN notice · CA
   CA71 workers · Layoff · effective Nov 1, 2024

WARN notices cover layoffs above the federal size thresholds in the states Palanor reads; they are not every layoff. A WARN notice filed near an 8-K Item 2.05 of Penumbra, Inc. is linked to it and counted once. Methodology and coverage

Charts

Live charts: each one redraws from today’s data and has an image link to paste into a document or slide.

In the news

Headlines that name Penumbra, Inc., with the publisher and a link. The tone is read from each headline’s own words, never from a summary of the article.

30 days

1 headlines

100% positive · 0% negative

90 days

1 headlines

100% positive · 0% negative

• Positive
  Penumbra (PEN) Highlights Wearable Device Data Linking Activity to Recovery in Pulmonary Embolism Trial

  gurufocus.com · via Marketaux · Oct 6, 2026

Filings and records

The last two years of notable 8-Ks, offerings, annual reports, federal awards, lobbying reports, patents and other public records, newest first.

1. Oct 13, 2026Patent
   Patent granted: VASCULAR OCCLUSION DETECTION FROM MOTORIZED SEPARATOR TORQUE MEASUREMENT SIGNALUS 12758250
2. Oct 6, 2026Patent
   Patent granted: Computer-Aided Vacuum Thrombectomy Systems and Methods for Estimating Therapeutic BenefitUS 12751729
3. Sep 22, 2026Patent
   Patent granted: Computer-Aided Vacuum Thrombectomy Systems and Methods for Controlled Clot AspirationUS 12740793
4. Sep 8, 2026Patent
   Patent granted: Apparatus and Methods for Controlled Clot AspirationUS 12727897
5. Jun 30, 2026Patent
   Patent granted: Aspiration Thrombectomy System and Methods for Dynamic System State DetectionUS 12667376
6. Jun 22, 20268-K
   Shareholder vote resultsItem 5.07
7. May 7, 20268-K
   Shareholder vote resultsItem 5.07
8. Feb 25, 202610-K
   Annual report (10-K)6 risk factors added, 0 removed
9. Jan 15, 20268-K
   Material agreement signedItem 1.01
10. Aug 27, 20258-K
    Director or officer changeItem 5.02
11. May 30, 20258-K
    Shareholder vote resultsItem 5.07
12. Mar 11, 2025Risk event
    Wage and Hour case: Penumbra Inc., back wages agreed$0.1 million
13. Feb 21, 20258-K
    Director or officer changeItem 5.02
14. Feb 18, 202510-K
    Annual report (10-K)2 risk factors added, 3 removed
15. Feb 22, 202410-K
    Annual report (10-K)0 risk factors added, 6 removed

Peers

Companies in the same industry in the S&P 500, Russell 1000 or MidCap 400, closest in revenue first. Trailing twelve months, from SEC filings.

Identity

SEC CIK

1321732

LEI

549300RGE06P3ECANU72

Wikidata

Q104822216